Kolorektalinė karcinoma (Lithuanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kolorektalinė karcinoma" in Lithuanian language version.

refsWebsite
Global rank Lithuanian rank
4th place
12th place
low place
3,677th place
2,374th place
1,384th place
1,389th place
900th place
1,226th place
2,869th place
2,650th place
8,725th place
222nd place
224th place
low place
5,887th place
234th place
131st place
low place
low place
2,393rd place
1,606th place
8,869th place
5,139th place
low place
low place
274th place
460th place
9,820th place
low place

aacrjournals.org

cancerres.aacrjournals.org

ascopubs.org

jco.ascopubs.org

bmj.com

gut.bmj.com

bmj.com

cghjournal.org

gastrojournal.org

jamanetwork.com

jama.jamanetwork.com

nature.com

nejm.org

nih.gov

ncbi.nlm.nih.gov

  • Giovannucci. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am, 2002. 31. http://www.ncbi.nlm.nih.gov/pubmed/12489270
  • Routine aspirin or nonsteroidal antiinflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 2007. 146(5). http://www.ncbi.nlm.nih.gov/pubmed/17339621
  • Winawer et al., Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 1997. 112(2).http://www.ncbi.nlm.nih.gov/pubmed/9024315
  • Cunningham et al. Colorectal cancer. Lancet. 2010 Mar 20;375(9719):1030-47. doi: 10.1016/S0140-6736(10)60353-4. http://www.ncbi.nlm.nih.gov/pubmed/20304247
  • Gill et al., Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol, 2004. 22(10). http://www.ncbi.nlm.nih.gov/pubmed/15067028
  • Habr-Gama et al., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg, 2004. 240(4). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356472/
  • Mulier, S., et al., Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol, 2008. 15(1). http://www.ncbi.nlm.nih.gov/pubmed/17906898
  • Poon et al., Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol, 1989. 7. http://www.ncbi.nlm.nih.gov/pubmed/2476530
  • Cunningham et al. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. Lancet Oncol. 2013 Oct;14(11):1077-85. doi: 10.1016/S1470-2045(13)70154-2. Epub 2013 Sep 10. http://www.ncbi.nlm.nih.gov/pubmed/24028813
  • Tabernero et al. Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial. Eur J Cancer. 2013 Oct 16. pii: S0959-8049(13)00853-8. doi: 10.1016/j.ejca.2013.09.013. http://www.ncbi.nlm.nih.gov/pubmed/24140268

oxfordjournals.org

jnci.oxfordjournals.org

rsna.org

pubs.rsna.org

springer.com

link.springer.com

thelancet.com

thieme-connect.com

wiley.com

onlinelibrary.wiley.com